First, although anti-FGFR4 treatment of CKD rats as well as lowering elevated FGF23 levels by taking mice off a high phosphate diet, reduce cardiac hypertrophy, these interventions seem to have little or no effect on cardiac fibrosis (164). This evidence concerns the gene FGFR4 and cardiac hypertrophy.